Drug Type TCR-T Cell therapy |
Synonyms Adoptive therapy with autologous MC2 TCR T cells, MC2 TCR T cells |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Squamous Cell Carcinoma of Head and Neck | Phase 2 | Netherlands | 20 Oct 2020 | |
Uveal Melanoma | Phase 2 | Netherlands | 20 Oct 2020 |